Publications by authors named "Erica Mumm"
Article Synopsis
- Minnesota expanded its viral genomic surveillance to include human respiratory syncytial virus (RSV).
- Whole-genome sequencing was performed on 575 specimens collected from healthcare facilities between July 2023 and February 2024.
- Two subgroups of RSV, A and B, showed distinct genomic differences, and researchers identified 23 clusters of genetically identical genomes.
Article Synopsis
- Respiratory syncytial virus (RSV) can severely impact infants and older adults, but there's limited knowledge regarding its effects on pregnant women.
- A study analyzed RSV hospitalizations in women aged 18-49, comparing pregnant and nonpregnant women across different time periods to assess severe outcomes.
- Results showed that pregnant women had fewer severe RSV cases, with no deaths reported among them, and more asymptomatic pregnant women were found during the pandemic due to changes in testing.
Healthcare personnel (HCP) are at potential risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in occupational and nonoccupational settings, even when fully vaccinated. This risk increased during Delta variant circulation. SARS-CoV-2 testing of fully vaccinated HCP working in the 14 days after exposure is important to prevent virus introduction into healthcare settings.
View Article and Find Full Text PDFThis report describes and contextualizes the high prevalence of mental health conditions (MHC) among Minnesota 2019 EVALI patients by examining the prevalence of MHC and associations between MHC and e-cigarette or vaping product (EVP) use in Minnesota population surveys. Investigators reviewed medical records for 140 EVALI patients to determine history of MHC. History of MHC and EVP use in the general population was estimated using self-reported measures and screening tools from two population-based surveys, the 2019 Minnesota Student Survey (MSS) and the 2018 Minnesota Behavioral Risk Factor Surveillance Survey (MN-BRFSS).
View Article and Find Full Text PDFSARS-CoV-2 Exposure and Infection Among Health Care Personnel - Minnesota, March 6-July 11, 2020.
MMWR Morb Mortal Wkly Rep
October 2020
Health care personnel (HCP) are at increased risk for infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), as a result of their exposure to patients or community contacts with COVID-19 (1,2). Since the first confirmed case of COVID-19 in Minnesota was reported on March 6, 2020, the Minnesota Department of Health (MDH) has required health care facilities* to report HCP exposures to persons with confirmed COVID-19 for exposure risk assessment and to enroll HCP with higher-risk exposures into quarantine and symptom monitoring. During March 6-July 11, MDH and 1,217 partnering health care facilities assessed 21,406 HCP exposures; among these, 5,374 (25%) were classified as higher-risk (3).
View Article and Find Full Text PDFArticle Synopsis
- During August-October 2019, the Minnesota Department of Health identified 96 patients with lung injuries linked to e-cigarette use, primarily related to THC products from informal sources.
- Analysis of vaping products from patients revealed that 24 contained vitamin E acetate, a compound of concern, and unlike products seized in 2018, all THC products collected in 2019 tested positive for it.
- While findings suggest a potential link between vitamin E acetate and EVALI, further research is needed to confirm causality and better understand the evolving market for these products.